CliffBio
small molecule

BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE

ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Loss of exclusivity—loss of exclusivity
CompanyJEROME STEVENS PHARMACEUTICALS INC

Drug detail

Brand nameBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
Active ingredientASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Strength325MG;50MG;40MG;30MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalAugust 1998
Marketing statusRX

More from JEROME STEVENS PHARMACEUTICALS INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE patent cliff — loss of exclusivity — | CliffBio